Search
for
Sort by
Research 121–150 of 253
- SRD5A2 and emerging therapies in androgen-driven disorders
- Insulin resistance as risk factor for the development of type 2 diabetes mellitus: a systematic approach
- Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome
- Mechanism of action of bolandiol (19-nortestosterone-3β,17β-diol), a unique anabolic steroid with androgenic, estrogenic, and progestational activities
- Coconut oil works as a gonadal feedback testosterone booster and increases pituitary aromatase (cyp19a1b) expression levels in fugu (Takifugu rubripes)
- Mixture effects of endocrine disrupting compounds in vitro
- Androgen Action in the Ovary
- Identification of a Cyclosporine-Specific P450 Hydroxylase Gene through Targeted Cytochrome P450 Complement (CYPome) Disruption in Sebekia benihana
- Lack of the Vitamin D Receptor is Associated with Reduced Epidermal Differentiation and Hair Follicle Growth
- The Biological Actions of Dehydroepiandrosterone Involves Multiple Receptors
- Corticotropin releasing hormone and the skin
- Intracrine androgen biosynthesis, metabolism and action revisited
- Polycystic ovary syndrome and its management: In view of oxidative stress
- Epidemiological study of prostate cancer (EPICAP): a population-based case–control study in France
- Sebaceous immunobiology - skin homeostasis, pathophysiology, coordination of innate immunity and inflammatory response and disease associations
- The Search for the Causes of Common Hyperandrogenism, 1965 to Circa 2015
- Antiandrogens as Therapies for COVID-19: A Systematic Review
- Mechanistic and therapeutic insight into the effects of cinnamon in polycystic ovary syndrome: a systematic review
- What does the research say about androgen use and cerebrovascular events?
- Comparative advantage and efficacy of natural products for polycystic ovary syndrome
- The Role of MicroRNA, Long Non-Coding RNA and Circular RNA in the Pathogenesis of Polycystic Ovary Syndrome: A Literature Review
- Hormonal and Genetic Etiology of Male Androgenetic Alopecia
- Androgenetic Alopecia in Polycystic Ovary Syndrome: A Cutaneous Marker of Systemic Metabo-inflammatory and Endocrine Dysfunction: A Narrative Review
- Understanding the Secular Decline in Testosterone: Mechanisms, Consequences, and Clinical Perspectives
- Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer
- The Current and Emerging Role of Statins in the Treatment of PCOS: The Evidence to Date
- New Target for Minoxidil in the Treatment of Androgenetic Alopecia
- Pharmacogenetics of the Androgen Metabolic Pathway
- Six Novel Susceptibility Loci for Early-Onset Androgenetic Alopecia and Their Unexpected Association with Common Diseases
- Hairless Suppresses Vitamin D Receptor Transactivation in Human Keratinocytes